Naloxone on release
The course provides guidelines for naloxone provision upon release from prison and other custodial settings. The immediate time after release (“my first 48 hours out”) is a critical time for action, when the cooperation between prisons, healthcare providers and NGOs is key in ensuring continuity of care and where targeted interventions can save lives from overdose and build a path towards engagement into further treatment and rehabilitation for people who use drugs.
This course will:
- advise policymakers of the practical steps necessary to introduce naloxone-on-release
- inform programme managers of the benefits of naloxone-on-release and provide advice on implementation.
This course aims to support prison doctors, prison health care workers, NGOs, people who come into contact with people who use drugs, GPs, nurses, teachers, police, housing workers and social workers and mental health workers.
Since there are variations in policy and guidelines by country, the course cannot reflect country-specific regulations. It presents general principles, to complement, not replace, national and international guidelines.
The course is a product of the “My first 48 hours out – comprehensive approaches to pre and post-prison release interventions for drug users in the criminal justice system” project.
Here you will find basic information about the course, about opioid overdose, and about the "My first 48 hours out" project.
Basic information and syllabus
This course is a product of the project “My first 48 hours out – comprehensive approaches to pre and post-prison release interventions for drug users in the criminal justice system”.
It aims to promote the implementation of life-saving interventions in prison and upon release with specific reference to harm reduction, overdose prevention and the use of naloxone programmes.
See more... Published: 2021Opioid overdose
Globally, overdose is a leading cause of premature death among people who inject drugs and the overwhelming majority of overdose fatalities involve opioids*. Worldwide, an estimated 69 000 people die from opioid overdose each year (WHO, 2014).
See more... Published: 2021What is Naloxone and how it works?
Naloxone is a medication that reverses the effect of opioids. In an emergency overdose situation, it can be a lifesaver. In this section you will learn how it works, as well as how and when it should be used.
See more... Published: 2021 Length: 3 minutesNaloxone in European Countries
Examples and further details regarding Naloxone status and use in the following European countries: United Kingdom, France and Italy .
See more... Published: 2021 Length: 7 minutesNaloxone in European Countries, continued
Provision of Naloxone and related legislation in Norway, Denmark, Germany and Spain.
See more... Published: 2021 Length: 2 minutesContext and Introduction
Rates of drug-related deaths in Scotland are among the highest in Europe. In 2016, 867 people lost their lives to preventable overdose deaths, the majority of which were accidental (National Records of Scotland, 2017).
In response to the rising number of opioid-related deaths, the Scottish Government introduced a National Naloxone Programme in 2010, which was launched in 2011.
See more... Published: 2021 Length: 3 minutesThe Scottish Model - Practical Steps
The aim of the prison naloxone programme is to train prisoners in overdose prevention, intervention and naloxone during their sentence and to provide them with naloxone-on-release. It is delivered by NHS staff and peers, facilitated by the Scottish Prison Service.
There are many steps along the ‘prisoner journey’ through their sentence where they have access to training. The steps listed here describe potential barriers and solutions to each phase.
See more... Published: 2021 Length: 4 minutesPeer Education, Effectiveness, and Areas of Improvement
The primary outcome for the effectiveness of the Scottish naloxone programme was to show a reduction in the number of opioid-related deaths within 4 weeks of liberation from prison.
These deaths decreased by 36% from 9.8 to 6.3% during the evaluation period.
See more... Published: 2021 Length: 5 minutesImplementation Guide - Policy Makers
The following guidance is based on the experience and learning from the Scottish National Naloxone Programme.
See more... Published: 2021 Length: 2 minutesImplementation Guide - Practitioners
When you finish the course, look into this section to find additional materials, both for self learning and for training others in lethal overdose prevention.
My First 48 Hours Out
This comic booklet was produced in the framework of the EU co-funded project “My first 48 hours out” – comprehensive approaches to pre and post prison release interventions for drug users in the criminal justice system”, implemented by the University of Applied Sciences in Frankfurt.
See more... Published: 2021 Length: 5 minutesOverdose prevention - bibliography and references
List of recommended resources on the topic of overdose prevention and Naloxone.
See more... Published: 2021 Length: 2 minutesUse of Naloxone - followup interview/report
Example form to be used as a brief guide to follow up on Naloxone use cases.
See more... Published: 2021Naloxone Poster and Leaflet
Overdose Prevention, Intervention and Naloxone Awareness Session
Example of an evaluation form for an "Overdose Prevention, Intervention and Naloxone Awareness Session"
See more... Published: 2021Naloxone Training - Sample Certificate
An example of a certificate to confirm completion of an overdose prevention, intervention and Naloxone training for trainers.
See more... Published: 2021Session Evaluation Template
Sample form of an overdose awareness or overdose intervention training session.
See more... Published: 2021Implementation checklist for Policy Makers and Practitioners
A brief one-page overdose prevention programme implementation checklist.
See more... Published: 2021Naloxone Training for Trainers
This course should provide an overview of drug-related deaths (DRDs) nationally and locally with an emphasis on overdose prevention, intervention and naloxone.
It should explore the causes of DRDs, risk factors, high risk times, myths and how to identify the signs and symptoms of an overdose.
There should be a focus on naloxone, its actions, kit assembly and administration with specific attention to the inclusion of naloxone in basic life support.
One-to-one Naloxone Training Checklist